Testing albendazole for Loa Loa infection
Treatments studied
Part of Infections, Skin clinical trials.
This trial tests if albendazole can lower the number of Loa Loa worms (microfilariae) in your blood. You will take a pill daily for 21 days, and researchers will monitor how well it works and how safe it is.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old
- You have been diagnosed with Loa Loa infection (microfilaremia)
- You weigh between 40 kg (88 lbs) and less than 90 kg (198 lbs)
- You are not pregnant or breastfeeding
- You have not taken albendazole or ivermectin in the past month
- You do not have serious liver, kidney, or blood problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a medicine called levamisole can safely reduce the number of loiasis (eye worm) parasites in your blood. You would take the medicine for 3 to 5 days and be monitored.
This study is testing a new rapid diagnostic test that aims to help eliminate onchocerciasis (river blindness). The test will be checked in people with different types of filarial worm infections (or no infection) to see how well it can tell them apart.
This trial tests how safe and effective a combined albendazole and ivermectin pill is for treating parasitic infections. It is for school-aged children in specific areas of Ghana and Kenya.
This study tests a new pill called lotilaner for safety and how well it works to kill mosquitoes that carry malaria. It is for healthy adults in Mali and may help future malaria prevention efforts.
This trial studies which dose of oxfendazole works best and is safest for treating a specific intestinal worm infection in adults. It compares different oxfendazole doses to one standard dose of albendazole, and uses stool and blood testing over about 4–6 weeks.
This study compares three medicines (albendazole, tribendimidine, and praziquantel) to see which works best for treating clonorchiasis (a liver fluke infection). If you have been diagnosed with this infection, this trial may help find the most effective treatment for you.
Hear when a new Loiasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.